Patrick J. Mcenany - Jan 30, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director, Chairman of Board of Directors
Signature
/s/ Patrick J. McEnany
Stock symbol
CPRX
Transactions as of
Jan 30, 2024
Transactions value $
$0
Form type
4
Date filed
1/31/2024, 05:01 PM
Previous filing
Jan 3, 2024
Next filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Options Exercise +26.3K +0.6% 4.41M Jan 30, 2024 Direct F1
transaction CPRX Common Stock, par value $0.001 per share Options Exercise +117K +2.64% 4.53M Jan 30, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Restricted Stock Units Options Exercise $0 -26.3K -0.96% $0.00 2.71M Jan 30, 2024 Common Stock 26.3K Direct F1, F2, F3
transaction CPRX Restricted Stock Units Options Exercise $0 -117K -4.31% $0.00 2.59M Jan 30, 2024 Common Stock 117K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2 Pursuant to a Separation Agreement between the Company and the Reporting Person, the Reporting Person's restricted stock units that would have vested within the fifteen month period following January 1, 2024 immediately vested.
F3 Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The shares were delivered on January 30, 2024.